Company intelligence
BioGaia AB
Clinically proven probiotics for the benefit of human health throughout life. Products available B2C & B2B worldwide.
About BioGaia AB
BioGaia is a Swedish probiotic company that has been at the forefront of microbiome research for more than 35 years. BioGaia develops, manufactures, markets, and sells probiotic products within the areas of gut health, oral health, and immune health. Our probiotic products with bacterial strains from the L. reuteri species are among the most scientifically well-documented probiotics. BioGaia`s products are distributed through own subsidiaries or distribution partners in more than 100 countries.The class B share of BioGaia is quoted on the Mid Cap list of the Nordic Exchange Stockholm.
Verified activity
Signals from BioGaia AB
6 published signals
Presence & Recognition
BioGaia AB attended the FDI World Dental Congress to connect with dental professionals and share the latest science behind BioGaia Prodentis.
Reported by BioGaia AB
Partnerships
BioGaia AB announced a new long-term exclusive distribution agreement with Recordati for Spain and Portugal.
Reported by BioGaia AB
Presence & Recognition
BioGaia AB is hosting the BioGaia Brilliant Minds Studio Symposium on 5 September at 12:30 in Room E2 to discuss the oral microbiome and probiotics for oral health.
Reported by BioGaia AB
Presence & Recognition
BioGaia AB is exhibiting at booth A43 at the FDI World Dental Congress 2026 in Prague.
Reported by BioGaia AB
People
BioGaia AB appointed Axel Appelgren as Regional Sales Director for EMEA.
Reported by BioGaia AB
Legal & Regulatory
BioGaia AB guarantees a minimum of 100 million live L. reuteri bacteria at the expiry date through extensive laboratory testing and rigorous quality controls.
Reported by BioGaia AB